Skip to main content
Equibles

Svetlana Makhni

CFO

Prime Medicine, Inc. (PRME)

Equibles does not estimate personal net worth.

Get an email with a short summary when Prime Medicine, Inc. publishes a filing, an earnings call transcript or a press release.

Get PRME alerts

About Svetlana Makhni

Svetlana Makhni is recorded as CFO at Prime Medicine, Inc. (PRME) since April 16, 2026. Prime Medicine, Inc. reported in an 8-K filed April 16, 2026 that Svetlana Makhni was appointed Chief Financial Officer and the principal financial officer, effective April 16, 2026. Prime Medicine, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Prime Medicine, Inc. includes Allan Reine (CEO and Board Member), Allan Reine, M.D. (CEO and Board Member), Jeffrey Marrazzo (Chairman) and 2 others.

“On April 7, 2026, the Board of Directors (the “Board”) of Prime Medicine, Inc. (the “Company”) appointed Svetlana Makhni as the Chief Financial Officer and the principal financial officer of the Company effective as of April 16, 2026.”
Prime Medicine, Inc. Form 8-K, filed April 16, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Prime Medicine, Inc.

Recent activity